Main Content

Press Release


REMINDER!

ELEKTA INVESTOR MEETING AT ASTRO ON NOVEMBER 6, 2006

Stockholm, October 30, 2006

In conjunction with ASTRO*, on Monday, November 6, at 2.00pm – approx. 4.30pm, Elekta will arrange an investors meeting at the Loew's Hotel in the "Washington A" room. Presenters will be Tomas Puusepp, President and CEO of Elekta, Anthony deCarolis, CEO of Elekta, Inc. and Jay Hoey, CEO of IMPAC Medical Systems, Inc.

Investors who want to attend the Investor Meeting are kindly requested to give notice ASAP by e-mail to ir@elekta.com.

*ASTRO, the American Society for Therapeutic Radiology and Oncology, annual meeting at the Pennsylvania Convention Center in Philadelphia, Pennsylvania on November 5-9 will be attended by 10,000 radiation oncologists, physicists, biologists, nurses and other healthcare professionals involved in the field of radiation oncology. Investors, who want to get a deeper knowledge about the radiation oncology market, technology development and the competitive situation, are recommended to visit this event. To obtain the ‘badge’ needed for admittance, please visit www.astro.org or buy such a badge at the registration desk on-site.

For further information, please contact ir@elekta.com.

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain surgery and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, The Elekta Group is the world’s largest supplier of oncology software.

Elekta’s systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.

With approx. 2,000 employees, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb.


This information was brought to you by Waymaker http://www.waymaker.net